ProShares Ultra Crcl (CRCA) closed at $9.68 on November 12, 2026, down 10.1% from the previous close, on volume of 279,990 shares (30-day average 420,405).
Data as of November 12, 2026.
No headlines found.
No press releases found.
No news found.
ProShares Ultra CRCL (the "Fund") seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of Class A common shares of Circle Internet Group, Inc. (NYSE: CRCL). Circle Internet Group, Inc. provides infrastructure for stablecoin and blockchain applications and is the issuer of a U.S. dollar-denominated stablecoin ("USDC") and a euro denominated stablecoin ("EURC", and collectively with USDC, "Circle stablecoins"). Under normal circumstances, the Fund will invest at least 80% of the Fund's assets in, or provide exposure to, financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The Fund will invest principally in the financial instruments listed below. Equity Securities Common stock issued by public companies. Derivatives The Fund invests in derivatives, which are financial instruments whose value is derived from the value of an underlying asset or assets, such as CRCL. The Fund invests in derivatives as a substitute for investing directly in securities in order to seek returns for a single day that are leveraged (2x) to the returns of CRCL for that day.
ProShares Ultra Crcl trades on the ARCA stock market under the symbol CRCA.
As of November 12, 2026, CRCA stock price declined to $9.68 with 279,990 million shares trading.
CRCA has a beta of 4.26, meaning it tends to be more sensitive to market movements. CRCA has a correlation of 0.09 to the broad based SPY ETF.
CRCA has a market cap of $60.56 million. This is considered a Micro Cap stock.
CRCA has underperformed the market in the last year with a price return of -85.2% while the SPY ETF gained +12.0%. CRCA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -34.9% and -41.2%, respectively, while the SPY returned -1.5% and -2.0%, respectively.
CRCA support price is $9.61 and resistance is $11.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CRCA shares will trade within this expected range on the day.
